Compared to the PB of ovarian cancer patients, the CD20+T cells were enriched in the ascitic fluid (23% vs. approximately 6% in the PB) suggesting a tumour-specific function of these cells [6]. The gene discussed is MS4A1; the disease is neoplasm.